Natasha Loder is The Economist’s health policy editor, covering a range of topics in medicine, technology, pharma and science, including an award-winning 2018 feature article on progress in cancer treatment. Between 2011 and 2014 Ms Loder worked as a foreign correspondent in Chicago, reporting on the Midwest, the bankruptcy of Detroit, education and agriculture. After joining The Economist in 2000 she spent a decade on the science desk, covering subjects ranging from the rise of the private space industry to the carbon cowboys of Papua New Guinea. Prior to joining The Economist Ms Loder worked at Nature, the Times Higher Education Supplement and Research Fortnight